p53 overexpression and downregulation of inter-α-inhibitor are associated with hyaluronidase enhancement of TNF cytotoxicity in L929 fibroblasts

This publication has 31 references indexed in Scilit:

• Hyaluronidase enhancement of TNF-mediated cell death is reversed by TGF-β1
  American Journal of Physiology-Cell Physiology, 1997
• Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma☆, ☆☆, ★
  Journal of the American Academy of Dermatology, 1997
• Reversal by Hyaluronidase of Adhesion-Dependent Multicellular Drug Resistance in Mammary Carcinoma Cells
  JNCI Journal of the National Cancer Institute, 1996
• Combined Application of Cisplatin, Vindesine, Hyaluronidase and Radiation for Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck
  American Journal of Clinical Oncology, 1995
• Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanoma
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1995
• Transforming Growth Factor-β1 Induction of Novel Extracellular Matrix Proteins That Trigger Resistance to Tumor Necrosis Factor Cytotoxicity in Murine L929 Fibroblasts
  Published by Elsevier ,1995
• Hyaluronidase induces murine L929 fibrosarcoma cells resistant to tumor necrosis factor and fas cytotoxicity in the presence of actinomycin D
  Cell Biochemistry and Biophysics, 1995
• Hyaluronidase enhances the activity of Adriamycin in breast cancer models in vitro and in vivo
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1992
• Topical Chemoprophylaxis of Superficial Bladder Cancer with Mitomycin C and Adjuvant Hyaluronidase
  European Urology, 1992
• Metaphylactic Effect of Mitomycin C with and without Hyaluronidase after Transurethral Resection of Bladder Cancer: Randomized Trial
  Journal of Urology, 1989